Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "twzip.com"

568
Business Relations
556
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 568
From Domain Role To Domain Path Aktionen
/elastos-unveils-bel2-sdks-for-partners-to-develop-native-bitcoin-apps-and-starbtc-demo-defi-app-to-extract-value-from-dormant-bitcoin/
/cryptoclicks-io-revolutionizes-crypto-marketing-with-influencer-focused-youtube-reviews/
/seaprwire/capital-revo-receives-prestigious-industry-award-for-excellence-in-financial-services/
/seaprwire/capital-revo-receives-prestigious-industry-award-for-excellence-in-financial-services/
/seaprwire/kepler-digitals-launches-the-avia-token-a-game-changer-for-aviation-sustainability-and-blockchain-innovation/
/business/dangbei-參與-amazon-德國-prime-big-deal-days,折扣高達-40/
/business/dangbei-參與-amazon-德國-prime-big-deal-days,折扣高達-40/
/seaprwire/virturo-unveils-next-gen-cfd-trading-platform-empowered-by-ai-and-human-expertise/
/seaprwire/mtt-sports-unveils-road-map-for-its-world-class-e-sports-tournament-platform/
/business/受規範的數位資產平台啟動-grade,旨在為代幣化證券/
/business/受規範的數位資產平台啟動-grade,旨在為代幣化證券/
/business/firmoo-推出-2025-2026-年時尚潮流眼鏡系列/
/seaprwire/intervision25-international-music-contest-to-take-place-michael-jacksons-descendant-expected-to-participate/
/seaprwire/intervision25-international-music-contest-to-take-place-michael-jacksons-descendant-expected-to-participate/
/seaprwire/fanroom-live-reaches-show-milestone-garnering-between-6-million-and-9-million-views-per-show-as-it-begins-its-star-studded-2025-season/
/seaprwire/proptech-farm-fund-iii-secures-initial-close-to-power-real-estate-technology-innovation-in-southeast-asia-and-australia/
/seaprwire/michael-owen-becomes-the-new-face-of-gk8-fastest-growing-igaming-brand/
/business/從輕微割傷到慢性傷口:dimora-的-phmb-潔膚液在家提供安/
/seaprwire/ifex-capital-launches-major-mobile-trading-app-overhaul-to-meet-surging-demand/
/seaprwire/s-biomedics-cell-therapy-for-parkinsons-disease-shows-positive-data-from-its-phase-1-2a-clinical-trial/